SENS PubMed Publication Search
New intranasal and injectable gene therapy for healthy life extension
Proc Natl Acad Sci U S A. 2022 May 17;119(20):e2121499119. doi: 10.1073/pnas.2121499119.
Dabbu Kumar Jaijyan 1, Anca Selariu 2, Ruth Cruz-Cosme 3, Mingming Tong 4, Shaomin Yang 5, Alketa Stefa 1 6, David Kekich 2, Junichi Sadoshima 4, Utz Herbig 1 6, Qiyi Tang 3, George Church 7, Elizabeth L Parrish 2, Hua Zhu 1
Abstract:
Using CMV as a gene therapy vector we illustrated that CMV can be used therapeutically as a monthly inhaled or intraperitoneally delivered treatment for aging-associated decline. Exogenous telomerase reverse transcriptase or follistatin genes were safely and effectively delivered in a murine model. This treatment significantly improved biomarkers associated with healthy aging, and the mouse lifespan was increased up to 41% without an increased risk of cancer...
PMID: 35537048
Free Full-Text: https://www.pnas.org/doi/10.1073/pnas.2121499119
Tags: Follistatin, gene therapy, lifespan extension, mice, TERT